RemediChain - Blockchain-based Medication Donations
Sector: Secondary sector · Industry: Pharmaceutical industry · Organisation: Good Shepherd Pharmacy, Lipscomb University, University of Memphis, Tuskegee University · Maturity level: Pilot
RemediChain uses blockchain technology to transparently track unused medications and safely distribute them to those in need. The project is in an FDA-approved pilot phase testing medication transfers in North Carolina, Indiana and Tennessee. The solution combines Enterprise Ethereum with Hyperledger Besu Client to ensure complete traceability and secure donation processes.
Documentation status
- Project status: Pilot
- Evidence: Evidence high
- Editorial review: Ufuk Avci, 15 April 2026
Description
RemediChain was founded in 2018 by Philip Baker PharmD — the founder of Good Shepherd Pharmacy (Memphis), a non-profit pharmacy for low-income patients. The concept: cancer patients whose treatment ends or who pass away often leave behind unopened, expensive medicines. RemediChain uses blockchain to safely and legally redistribute these to patients in need.
The challenge: legally redistributing unused prescription medicines in the USA is complex — liability issues, proof of quality, regulatory requirements. RemediChain solves this through blockchain-based legality and quality documentation: donors register unopened medicines; RemediChain records serial number, expiry date, cold chain status and donor identity on the blockchain; recipient pharmacies can verify the full history of each unit. April 2019: The FDA approved a multi-regional pilot project (DSCSA implementation study) in North Carolina, Indiana and Tennessee — launched August 2019. Consortium: Good Shepherd Pharmacy + RemediChain, Rymedi (blockchain platform), Temptime/Zebra Technologies (IoT temperature sensors), Indiana University Health, WakeMed Hospitals, Center for Supply Chain Studies, Global Health Policy Institute (UC San Diego). Outcome: RemediChain claims to have prevented $17 million in pharmaceutical waste and enabled thousands of patients to access vital medicines.
Perspectives
B2B — organisations perspective
Cancer centres and clinics can securely and DSCSA-compliantly pass on unopened donated medicines via RemediChain: blockchain proves authenticity and quality, smart contracts regulate the compliant transfer.
B2C — consumers perspective
Cancer patients without insurance coverage gain access to donated cancer medicines through RemediChain — blockchain-verified quality and origin protect against inferior or counterfeit products.
Employees perspective
Pharmacy staff receive digital tools through RemediChain for efficient management of medicine donations and can simplify their work through transparent processes. The system enables pharmacists to fulfil their social responsibility while meeting regulatory requirements.
Benefits
General
- RemediChain reduces massive medicine waste through a transparent and secure redistribution system.
- The system builds trust among all parties through seamless documentation and FDA-compliant processes.
- Blockchain technology enables complete traceability from donation to end recipient.
B2B — organisations
- Pharmacies can reduce their compliance costs while demonstrating their social commitment.
B2C — consumers
- Patients in need gain secure access to high-quality medicines through a trusted system.
Employees
- Pharmacists receive digital tools that simplify their daily work managing medicines.
Challenges
General
- Implementation requires complex integrations with existing pharmacy systems and regulatory approvals.
- Building a trusted network between donors and recipients requires time and continuous communication.
B2B — organisations
- Companies must invest in new technologies and train their staff accordingly.
Employees
- Staff must adapt to new digital processes and learn blockchain basics.
Technology foundation
RemediChain uses a hybrid solution of Enterprise Ethereum with Hyperledger Besu client and a Proof-of-Authority consensus mechanism. This technology enables seamless tracking of every medicine donation while controlling access to sensitive data, thereby building trust among all parties.
Implementation examples
FDA pilot project RemediChain
The project addresses the massive waste of medicines in the USA, where millions of dollars worth of unused drugs are discarded annually. At the same time, it aims to enable patients in need to access essential medicines.
Good Shepherd Pharmacy is conducting an FDA-approved pilot project testing blockchain-based medication transfers in three US states.
Good Shepherd Pharmacy is collaborating with a consortium including Rymedi, Temptime/Zebra Technologies, Indiana University Health, WakeMed Hospitals and Health, and other partners to conduct an FDA-approved pilot project. The project tests medication transfers in North Carolina, Indiana, and Tennessee using a hybrid blockchain solution with Enterprise Ethereum and Hyperledger Besu Client. The pilot phase demonstrates functionality on a limited testnet platform and lays the foundation for later scaling to additional US states.
The solution creates transparency and trust in medication donations through seamless blockchain-based documentation. Regulatory compliance is ensured by FDA-approved processes and secure traceability.
Tags
Medicine donations, Pharma logistics, Traceability, Social responsibility, FDA compliance